Yelensky Roman 4
4 · Gritstone Oncology, Inc. · Filed Apr 16, 2021
Insider Transaction Report
Form 4
Yelensky Roman
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-03-08$0.76/sh+50,724$38,500→ 183,948 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1]2021-03-08−50,724→ 0 totalExercise: $0.76Exp: 2027-02-07→ Common Stock (50,724 underlying)
Footnotes (1)
- [F1]Fully exercisable.
Signature
/s/ Rahsaan Thompson, Attorney-in-Fact for Roman Yelensky|2021-04-16